Nanomerics Awarded an MHRA Innovation Passport for OC134
LONDON, UK / ACCESSWIRE / August 31, 2022 / Nanomerics Ltd., a private speciality pharmaceutical company, today announced that the Company had received an Innovation Passport from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) for its …